Differing requirement for inducible nitric oxide synthase activity in clearance of primary and secondary Cryptococcus neoformans infection

References

• Hayashi S, Chan CC, Gazzinelli R, Roberge G. Contribution of NO to the host-parasite equilibrium in toxoplasmosis. J Immunol 1996; 156: 1476–1481.
   Google Scholar
• Khan IA, Schwartzman JD, Matsuura T, Kasper LH. A di-chotomous role for NO during acute Toxoplasma gondii infec-tion in mice. Proc Natl Acad Sci 1997; 94: 19355–19360.
   Google Scholar
• Khan IA, Matsuura T, Kasper LH. Inducible NO synthesis is not required for long-term vaccine-based immunity against Toxoplasma gondii. J Immunol 1998; 161: 2994–3000.
   Google Scholar
• Wynn TA, Osward D, Eltoum IA, et al. Elevated expression of TH1 cytokines and nitric oxide synthase in the lungs of vacci-nated mice after challenge with Schistosoma mansoni. J Im-munol 1994; 153: 5200–5209.
   Google Scholar
• Liew FY, Millott S, Paranson C, Palmre RMJ, Moncada S. Macrophage killing of Leishmania parasite in vivo is mediated by nietric oxide from L-arginine. J Immunol 1990; 144: 4794–4797.
   Google Scholar
• Evans TG, Granger DL, Hibbs JB Jr. Effect of in vivo inhibi-tion of NO production in murine leishmaniasis. J Immunol 1993; 151: 907–915.
   Google Scholar
• Boockvar KS, Granger DL, Poston RM, et al. Nitric oxide produced during murine listeriosis is protective. Infect Immun 1994; 62: 1089–1100.
   Google Scholar
• Chan J, Tanaka K, Carroll D, Flynn J, Bloom BR. Effects of nitric oxide synthase inhibitors on murine infection with My-cobacterium tuberculosis. Infect Immun 1995; 63: 736–740.
   Google Scholar
• MacMicking JD, North RJ, LaCourse R, Mudgett JS, Shah SK, Nathan C. Identification of NO synthase as a protective locus against tuberculosis. Proc Natl Acad Sci 1997; 94: 5243–5248.
   PubMed Web of Science ®Google Scholar
• Karupiah G, Xie OW, Buller RM, Nathan C, Duarte C, MacMicking JD. Inhibition of viral replication by interferon-gamma-induced nitric oxide synthase. Science 1993; 261: 1445–1448.
   PubMed Web of Science ®Google Scholar
• Alspaugh JA, Granger DL. Inhibition of Cryptococcus neofor-mans replication by nitrogen oxides supports the role of these molecules as effectors of mac-mediated cytostasis. Infect Immun 1991; 59: 2291–2296.
   PubMedGoogle Scholar
• Lee SC, Dickson DW, Brosnan CW, Casadevall A. Human astrocytes inhibit Cryptococcus neoformans growth by a nitric oxide-mediated mechanism. J Exp Med 1994; 180: 365–369.
   PubMed Web of Science ®Google Scholar
• Lovchik JA, Lyons CR, Lipscomb MF. A role for gamma-in-terferon induced nitric oxide in pulmonary clearance of Crypto-coccus neoformans. Am J Respir Cell Mol Biol 1995; 13: 116–124.
   Google Scholar
• Goldman D, Cho Y, Zhao M, Casadevall A, Lee SC. Expres-sion of inducible nitric oxide synthase in rat pulmonary Crypto-coccus neoformans granulomas. Am J Pat ho! 1996; 148: 1275–1282.
   Google Scholar
• Tohyama M, Kawakami K, Futenma M, Saito A. Enhancing effect of oxygen radical scavengers on murine macrophage anticryptococcal activity through products of nitric oxide. Clin Exp Immunol 1996; 103: 436–441.
   PubMed Web of Science ®Google Scholar
• Lovchik JA, Lipscomb MF, Lyons CR. Expression of lung inducible nitric oxide synthase protein does not correlate with nitric oxide products in vivo in a pulmonary immune response against Cryptococcus neoformans. J Immunol 1997; 158: 1772–1778.
   Google Scholar
• Kawakami K, Tohyama M, Qifmg X, Saito A. Expression of cytokines and INOS mRNA in the lungs of mice infected with Cryptococcus neoformans: effects of interleukin-12. Infect Im-man 1997; 65: 1307–1312.
   PubMed Web of Science ®Google Scholar
• Mozaffarian N, Berman JW, Casadevall A. Enhancement of nitric oxide synthesis by macrophages represents an additional mechanism of action for amphotericin B. Antimicrob Agents Chemother 1997; 41: 1825–1829.
   Google Scholar
• Hoag KA, Lipscomb MF, Izzo AA, Street NE. IL-12 and interferon-gamma are required for initiating the protective Th 1 response to pulmonary cryptococcosis in resistant C.B-17 mice. Am J Respir Cell Mol Biol 1997; 17: 733–739.
   Google Scholar
• Blasi E, Barluzzi R, Mazzolla R, et al. Role of nitric oxide and melanogenesis in the accomplishment of anticryptococcal activ-ity by the BV-2 microglial cell line. J Neuroimmunol 1995; 58: 111–116.
   PubMedGoogle Scholar
• Mitchell TG, Perfect JR. Cryptococcosis in the era of AIDS — 100 years after the discovery of Cryptococcus neoformans. Clin Micro Rev 1995; 8: 515–548.
   PubMed Web of Science ®Google Scholar
• Jacobson ES, Emery HS. Catecholamine uptake, melanization, and oxygen toxicity in Cryptococcus neoformans. J Bacteriol 1991; 173: 401–403.
   PubMedGoogle Scholar
• Wang Y, Casedevall A. Susceptibility of melanizekl and non-melanizekl Cryptococcus neoformans to nitrogen and oxygen-derived oxidants. Infect Immun 1994; 60: 3004–3007.
   Google Scholar
• Rossi GR, Sastre DA, Rubinstein HR, Masih DT. Biochemical basis for the killing of Cryptococcus neoformans by rat peri-toneal cells. J Exp Med Vet Mycol 1994; 32: 405–414.
   PubMedGoogle Scholar
• Wang Y, Aisen P, Casadevall A. Cryptococcus neoformans melanin and virulence; mechanisms of action. Infect Immun 1995; 63: 3131–3136.
   Google Scholar
• Chaturvedi V, Wong B, Newman SL. Oxidative killing of Cryptococcus neoformans by human neutrophils. Evidence that fungal mannitol protects by scavenging reactive oxygen inter-mediates. J Immunol 1996; 156: 3836–3840.
   Google Scholar
• Xie Q, Kawakami K, Kudeken N, Thong T, Qureshi MH, Saito A. Different susceptibility of 3 clinically-isolated strains of Cryptococcus neoformans to the fungicidal effects of reactive nitrogen and oxygen intermediates: possible relationship with virulence. Microbial Immunol 1997; 41: 725–731.
   Google Scholar
• Lehrer RI, Ladra KM. Fungicidal components of mammalian granulocytes active against Cryptococcus neoformans. J Infect Dis 1977; 136: 96–99.
   Google Scholar
• Ganz T, Selsted ME, Szklarek D, et al. Defensins: Natural peptide antibiotics of human neutrophils. J Clin Invest 1985; 76: 1427–1435.
   PubMed Web of Science ®Google Scholar
• Vecchiarelli A, Pietrella D, Dottorini M, et al. Encapsulation of Cryptococcus neoformans regulates fungicidal activity and the antigen presentation process in human alveolar macrophages. Clin Exp Immunol 1994; 98: 217–223.
   PubMed Web of Science ®Google Scholar
• Hiemstra PM, Eisenhauer PB, Harwig S, van der Barsekaar MT, van Furth R, Lehrer RI. Antimicrobial proteins of murine macrophages. Infect Immun 1993; 61: 3038–3046.
   Google Scholar
• MacMicking JD, Nathan C, Hom G, et al. Altered responses to bacterial infection and endotoxic shock in mice lacking in-ducible nitric oxide synthase. Cell 1995; 81: 641–650.
   PubMed Web of Science ®Google Scholar
• Dalton DK, Pitts-Meek S, Keshav S, Figari IS, Bradley A, Stewart TA. Multiple defects of immune cell function in mice with disrupted interferon-gamma genes. Science 1993; 259: 1739–1742.
   PubMed Web of Science ®Google Scholar
• Murphy JW, Cozad GC. Immunological unresponsiveness in-duced by cryptococcal polysaccharide assayed by the hemolytic plaque technique. Infect Immun 1972; 5: 896–901.
   PubMed Web of Science ®Google Scholar
• Edman JC, Kwon-Chung KJ. Isolation of the URA5 gene from Cryptococcus neoformans var. neoformans and its use as a selective marker for transformation. Mol Cell Biol 1990; 10: 4538–4544.
   Google Scholar
• Hill JO, Harmsen AG. Intrapulmonary growth and dissemina-tion of an avirulent strain of Cryptococcus neoformans in mice depleted of CD4 ± and CD8 ± T cells. J Exp Med 1991; 173: 755–758.
   PubMed Web of Science ®Google Scholar
• Aguirre KM, Sayles PC, Gibson GW, Johnson LL. Resistance to Cryptococcus neoformans is asociated with an inflammatory response to Toxoplasnza gondii in the central nervous system of mice. Infect Immun 1996; 64: 77–82.
   Google Scholar
• Aguirre KM, Garvy BA, Johnson LL. Acquired resistance to Cryptococcus neoformans in adult mice vaccinated as newborns. Infect Immun 1997; 65: 1688–1694.
   Google Scholar
• Haven EA. Evidence that tumor necrosis factor has an impor-tant role in antibacterial resistance. J Immunol 1989; 143: 2894–2899.
   Google Scholar
• Hill JO, Aguirre KM. CD4 ± T cell-dependent acquired state of immunity that protects the brain against Cryptococcus neofor-mans. J Immunol 1994; 152: 2344–2350.
   PubMed Web of Science ®Google Scholar
• Aguirre KM, Johnson LL. A role for B cells in resistance to Cryptoocccus neoformans in mice. Infect Immun 1997; 65: 525–530.
   PubMed Web of Science ®Google Scholar
• Levitz SM, DeBenedetto DJ. Paradoxical role of capsule in murine bronchoalveolar macrophage-mediated killing of Cryp-tococcus neoformans. J Immunol 1989; 142: 659–665.
   PubMed Web of Science ®Google Scholar
• Naslund PK, Miller WC, Granger D. Cryptococcus neoformans fails to induce nitric oxide synthase in primed murine macrophage-like cells. Infect Immun 1995; 63: 1298–1304.
   Google Scholar